» Articles » PMID: 39930199

Proposing Zebrafish As a Model for Stargardt Disease

Overview
Date 2025 Feb 10
PMID 39930199
Authors
Affiliations
Soon will be listed here.
Abstract

Stargardt disease (STGD1) is an inherited juvenile macular degeneration caused by mutations in the ATP-binding cassette subfamily A member 4 gene (ABCA4), a flippase located in the photoreceptor outer segment. ABCA4 mutations cause the buildup of a toxic byproduct in the retina called lipofuscin resulting in the death of photoreceptors by ferroptosis. Mammalian disease models (e.g., mouse Abca4) have been established, but do not replicate all the disease symptoms in human STGD1 patients. It is challenging to model a cone degeneration disease like STGD1 using mice. Here we suggest zebrafish (Danio rerio) as a STGD1 model. This widely used vertebrate model organism is popular in the ocular field due to the early development of a cone-rich retina and the ability to correlate genotypes with relevant phenotypes. Zebrafish have been used to successfully model cone photoreceptor diseases including gene editing and drug-induced models. We propose zebrafish as a suitable diurnal model for STGD1.

References
1.
Bilotta J, Saszik S, Sutherland S . Rod contributions to the electroretinogram of the dark-adapted developing zebrafish. Dev Dyn. 2001; 222(4):564-70. DOI: 10.1002/dvdy.1188. View

2.
Brockerhoff S . Measuring the optokinetic response of zebrafish larvae. Nat Protoc. 2007; 1(5):2448-51. DOI: 10.1038/nprot.2006.255. View

3.
Chhetri J, Jacobson G, Gueven N . Zebrafish--on the move towards ophthalmological research. Eye (Lond). 2014; 28(4):367-80. PMC: 3983641. DOI: 10.1038/eye.2014.19. View

4.
Cremers F, Lee W, Collin R, Allikmets R . Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations. Prog Retin Eye Res. 2020; 79:100861. PMC: 7544654. DOI: 10.1016/j.preteyeres.2020.100861. View

5.
Deeti S, OFarrell S, Kennedy B . Early safety assessment of human oculotoxic drugs using the zebrafish visualmotor response. J Pharmacol Toxicol Methods. 2013; 69(1):1-8. DOI: 10.1016/j.vascn.2013.09.002. View